STAT News

STAT+: Pharmalittle: We’re reading about the 340B drug pilot program, an obesity drug disappointment, and more

The U.S. approved 10 drugmakers to participate in a 340B pilot program that will allow them to offer rebates, instead of upfront discounts, to certain providers

By STAT News

1 min read
STAT+: Pharmalittle: We’re reading about the 340B drug pilot program, an obesity drug disappointment, and more
STAT+: Pharmalittle: We’re reading about the 340B drug pilot program, an obesity drug disappointment, and more

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights